Ownership history in VANGUARD GROUP INC · 32 quarters on record
This page tracks every 13F SEC filing in which VANGUARD GROUP INC reported a position in SCPHARMACEUTICALS INC (SCPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 2,176,970 | +341,321 | +18.6% | 0.00% | $12.3M | — |
| 2025 Q2 | REDUCED | 1,835,649 | -157,111 | -7.9% | 0.00% | $7.0M | — |
| 2025 Q1 | REDUCED | 1,992,760 | -115,697 | -5.5% | 0.00% | $5.2M | — |
| 2024 Q4 | ADDED | 2,108,457 | +399,511 | +23.4% | 0.00% | $7.5M | — |
As of 2025 Q3 — sorted by position size